These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
426 related items for PubMed ID: 23590130
1. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing. Lee SR, Jung CK, Kim TE, Bae JS, Jung SL, Choi YJ, Kang CS. Thyroid; 2013 Nov; 23(11):1416-22. PubMed ID: 23590130 [Abstract] [Full Text] [Related]
3. BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma. Park JY, Kim WY, Hwang TS, Lee SS, Kim H, Han HS, Lim SD, Kim WS, Yoo YB, Park KS. Endocr Pathol; 2013 Jun; 24(2):69-76. PubMed ID: 23625203 [Abstract] [Full Text] [Related]
4. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Strickland KC, Eszlinger M, Paschke R, Angell TE, Alexander EK, Marqusee E, Nehs MA, Jo VY, Lowe A, Vivero M, Hollowell M, Qian X, Wieczorek T, French CA, Teot LA, Cibas ES, Lindeman NI, Krane JF, Barletta JA. Endocr Pathol; 2018 Mar; 29(1):68-74. PubMed ID: 29396809 [Abstract] [Full Text] [Related]
9. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G. Thyroid; 2009 Aug 13; 19(8):837-42. PubMed ID: 19534623 [Abstract] [Full Text] [Related]
10. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis. Park SJ, Sun JY, Hong K, Kwak JY, Kim EK, Chung WY, Choi JR. Clin Chem Lab Med; 2013 Aug 13; 51(8):1673-80. PubMed ID: 23585181 [Abstract] [Full Text] [Related]
11. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status. Walts AE, Mirocha JM, Bose S. J Cancer Res Clin Oncol; 2015 Oct 13; 141(10):1749-56. PubMed ID: 25702102 [Abstract] [Full Text] [Related]
13. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma. Song YS, Won JK, Yoo SK, Jung KC, Kim MJ, Kim SJ, Cho SW, Lee KE, Yi KH, Seo JS, Park YJ. Thyroid; 2018 Nov 13; 28(11):1468-1478. PubMed ID: 30226444 [Abstract] [Full Text] [Related]
15. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Eloy C, Santos J, Soares P, Sobrinho-Simões M. Virchows Arch; 2011 Sep 13; 459(3):265-76. PubMed ID: 21796448 [Abstract] [Full Text] [Related]
16. Follicular variant of papillary thyroid carcinoma: accuracy of FNA diagnosis and implications for patient management. Ustun B, Chhieng D, Prasad ML, Holt E, Hammers L, Carling T, Udelsman R, Adeniran AJ. Endocr Pathol; 2014 Sep 13; 25(3):257-64. PubMed ID: 24696132 [Abstract] [Full Text] [Related]
17. Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities. Gupta S, Ajise O, Dultz L, Wang B, Nonaka D, Ogilvie J, Heller KS, Patel KN. Arch Otolaryngol Head Neck Surg; 2012 Mar 13; 138(3):227-33. PubMed ID: 22431868 [Abstract] [Full Text] [Related]